Neurocrine Biosciences Announces CEO Succession Plan PR Newswire SAN DIEGO, May 28, 2024 Board of Directors appoints Kyle Gano , Ph.D., Chief Business Development and Strategy Officer, as CEO-elect, effective October 11, 2024 Kevin Gorman , Ph.D., to continue to serve on the Neurocrine Board of Directors SAN DIEGO , May 28, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced that Kevin Gorman , Ph.D., will retire as Chief Executive Officer of Neurocrine on October...